Biology of Blood and Marrow Transplantation
Volume 16, Issue 3 , Pages 311-319 , March 2010

Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease

  • Lisa A. Palmer

      Affiliations

    • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • George E. Sale

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • John I. Balogun

      Affiliations

    • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Dan Li

      Affiliations

    • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Dan Jones

      Affiliations

    • Department of Hemapathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Jeffrey J. Molldrem

      Affiliations

    • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Rainer F. Storb

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
    • ,
  • Qing Ma

      Affiliations

    • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • Corresponding Author InformationCorrespondence and reprint requests to: Qing Ma, Section of Transplant Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Unit 900, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 6 August 2009 ,Accepted 1 December 2009.

References 

  1. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385–389
  2. Sale GE. The Pathology of Organ Transplantation. London: Butterworth Publishers, Inc.; 1990;229-260
  3. Ferrara JLM, Antin JH. The pathophysiology of graft-versus-host disease. In:  Thomas ED,  Blume KG,  Forman SJ editor. Hematopoietic Cell Transplantation. Boston, MA: Blackwell Scientific Publications; 1994;p. 305–315
  4. Sale GE. Does graft-versus-host disease attack epithelial stem cells?. Mol Med Today. 1996;2:114–119
  5. Fowler DH, Gress RE. Graft-versus-host disease as a Th1-type process: regulation by donor cells of Th2 cytokine phenotype. In:  Ferrara JLM,  Deeg HJ,  Burakoff SJ editor. Graft-vs.-Host Disease. New York: Marcel Dekker Inc.; 1997;p. 479–500
  6. Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res. 2000;9:299–306
  7. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2:102–107
  8. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2:123–128
  9. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 2002;16:1–4
  10. Garzino-Demo A, DeVico AL, Conant KE, Gallo RC. The role of chemokines in human immunodeficiency virus infection. Immunol Rev. 2000;177:79–87
  11. Tomiyama H, Matsuda T, Takiguchi M. Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J Immunol. 2002;168:5538–5550
  12. Fukada K, Sobao Y, Tomiyama H, Oka S, Takiguchi M. Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells. J Immunol. 2002;168:2225–2232
  13. Murai M, Yoneyama H, Harada A, et al. Related active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest. 1999;104:49–57
  14. Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier. Blood. 1999;93:43–50
  15. Serody JS, Burkett SE, Panoskaltsis-Mortari A, et al. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease. Blood. 2000;96:2973–2980
  16. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol. 2003;4:154–160
  17. Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol. 2004;173:845–854
  18. Panoskaltsis-Mortari A, Hermanson JR, Taras E, Wangensteen OD, Serody JS, Blazar BR. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice. Blood. 2003;101:3714–3721
  19. Merad M, Hoffmann P, Ranheim E, et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med. 2004;5:510–517
  20. Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS. The role of B Cells in the pathogenesis of graft-versus-host disease. Blood. 2009;2009 Sep 11 [Epub ahead of print]
  21. Gros E, Bussmann C, Bieber T, Förster I, Novak N. Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol. 2009;124:753–760
  22. Santegoets SJ, Gibbs S, Kroeze K, et al. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol. 2008;84:143–151
  23. Segerer S, Cui Y, Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis. 2001;37:518–531
  24. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet. 2001;357:1758–1761
  25. Ma Q, Gooley TA, Storb RF. CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease. Biol Blood Marrow Transplant. 2009;doi: 10.1016/j.bbmt.2009.05.003
  26. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962–968
  27. Xing D, Decker WK, Li S, et al. AML-loaded DC generate Th1-type cellular immune responses in vitro. Cytotherapy. 2006;8:95–104
  28. Martins SL, St John LS, Champlin RE, et al. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. Blood. 2004;104:3429–3436
  29. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121–127
  30. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875–883
  31. Chtanova T, Mackay CR. T cell effector subsets: extending the Th1/Th2 paradigm. Adv Immunol. 2001;78:233–266
  32. Jaksch M, Remberger M, Mattsson J. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:280–287
  33. Takahashi N, Sato N, Takahashi S, Tojo A. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation. Exp Hematol. 2008;36:1760–1770
  34. Bogunia-Kubik K, Duda D, Suchnicki K, Lange A. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Haematologica. 2006;91:1628–1634
  35. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108–115
  36. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002;2:106–115
  37. De Clercq E. New anti-HIV agents and targets. Med Res Rev. 2002;22:531–565
  38. Horuk R. Development and evaluation of pharmacological agents targeting chemokine receptors. Methods. 2003;29:369–375
  39. Dhami H, Fritz CE, Gankin B, et al. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies. J Clin Pharm Ther. 2009;34:147–160

 Financial disclosure: See Acknowledgments on page 318.

PII: S1083-8791(09)00586-2

doi: 10.1016/j.bbmt.2009.12.002

Biology of Blood and Marrow Transplantation
Volume 16, Issue 3 , Pages 311-319 , March 2010

Article Tools

* Image Usage & Resolution